These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 9700577)
1. Expression of neuron-specific enolase, chromogranin A, synaptophysin and Leu-7 in lung cancer cell lines. Poola I; Graziano SL J Exp Clin Cancer Res; 1998 Jun; 17(2):165-73. PubMed ID: 9700577 [TBL] [Abstract][Full Text] [Related]
2. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines. Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288 [TBL] [Abstract][Full Text] [Related]
3. Chromogranin A gene expression in non-small cell lung carcinomas. Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430 [TBL] [Abstract][Full Text] [Related]
4. [Detection of neuroendocrine differentiation in NSCLC and its clinical significance]. Ouyang N; Chen G; Ding J Zhonghua Jie He He Hu Xi Za Zhi; 2001 Feb; 24(2):90-2. PubMed ID: 11802946 [TBL] [Abstract][Full Text] [Related]
5. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021 [TBL] [Abstract][Full Text] [Related]
6. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329 [TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer. Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076 [TBL] [Abstract][Full Text] [Related]
8. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma]. Yu SP; Xiong YY; Tian SF Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):165-8. PubMed ID: 12816683 [TBL] [Abstract][Full Text] [Related]
9. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features. Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117 [TBL] [Abstract][Full Text] [Related]
10. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma. Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784 [TBL] [Abstract][Full Text] [Related]
11. The expression of selected neuroendocrine markers and of anti-neoplastic cytokines (IL-2 and IL-12) in lung cancers. Kasprzak A; Przewoźna M; Surdyk-Zasada J; Zabel M Folia Morphol (Warsz); 2003 Nov; 62(4):497-9. PubMed ID: 14655151 [TBL] [Abstract][Full Text] [Related]
13. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA. Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150 [TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine differentiation as an indicator of chemosensitivity and prognosis in nonsmall cell lung cancer. Petrović M; Baskić D; Banković D; Ilić N Biomarkers; 2011 Jun; 16(4):311-20. PubMed ID: 21595568 [TBL] [Abstract][Full Text] [Related]
15. Secretagogin is a new neuroendocrine marker in the human prostate. Adolf K; Wagner L; Bergh A; Stattin P; Ottosen P; Borre M; Birkenkamp-Demtröder K; Orntoft TF; Tørring N Prostate; 2007 Apr; 67(5):472-84. PubMed ID: 17285592 [TBL] [Abstract][Full Text] [Related]
16. Expression of vesicular monoamine transporters, synaptosomal-associated protein 25 and syntaxin1: a signature of human small cell lung carcinoma. Graff L; Castrop F; Bauer M; Höfler H; Gratzl M Cancer Res; 2001 Mar; 61(5):2138-44. PubMed ID: 11280778 [TBL] [Abstract][Full Text] [Related]
18. Expression of neuroendocrine and epithelial markers in an adherent subline derived from a classic small cell lung cancer cell line. Walker C; Wright-Perkins S Oncol Res; 1992; 4(10):419-29. PubMed ID: 1337994 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of tumor markers in the management of small cell lung cancer]. Ariyoshi Y Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):959-65. PubMed ID: 2839115 [TBL] [Abstract][Full Text] [Related]
20. Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma. Matsuki Y; Tanimoto A; Hamada T; Sasaguri Y Mod Pathol; 2003 Jan; 16(1):72-8. PubMed ID: 12527716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]